BJP Indian Subcontinent Life Science Opinion

IIT Scientists predicts for India 3-4million active cases and 4.4 lakhs new cases per day during Mid may

The scientists from the Indian Institute of Technology in Kanpur and Hyderabad applied the Susceptible, Undetected, Tested (positive), and Removed Approach’ (SUTRA) model to predict that active cases would go up further by over 10 lakh by mid-May.   Active cases in the ongoing second COVID-19 wave in India may peak at 38-48 lakh between Read More…

Corona Virus Health Indian Subcontinent Life Science medical

Covaxin joins ‘clinical trial mode’ label free vaccination club

Bharat Biotech’s COVID-19 vaccine, Covaxin, will no longer have to carry the ‘clinical trial mode’ label.  The ‘clinical trial mode’ label meant that the manufacturer of Covaxin, Bharat Biotech had to seek informed consent before administering its vaccine to those eligible for the government’s ongoing vaccination drive.   It also meant the company had to Read More…

Asia Canada Companies Corona Virus Europe Indian Subcontinent Life Science Life Style medical Opinion

Vaccination phase in India on 50th day cross 20million

The total number of COVID-19 vaccine doses administered in India has crossed 2.06 crore, the Union Health Ministry said on Saturday.   The nationwide vaccination drive against COVID-19 was rolled out on January 16 with healthcare workers, while frontline workers stated receiving vaccine shots from February 2. Providing the second dose of COVID-19 shots started Read More…

Corona Virus Health High Court Indian Subcontinent Life Science

We are donating or selling vaccines to foreign countries rather giving to its our own people : Delhi High Court

Delhi high court Justice Vipin Sanghi made strong observations while hearing a suo motu public interest litigation   This is when concerning vaccination of judges, court staff and lawyers on priority and for them to be treated as frontline workers so that they could receive it without limitations of their age or physical condition.   Read More…

Corona Virus Health Indian Subcontinent Life Science Opinion

Reason for snail phase of vaccination in India revealed by ICMR Dr. Arora

Covid-19 vaccination pace deliberately kept low, explains ICMR doctor  One-third of those who have already contracted Covid-19 do not develop antibodies required, Dr NK Arora explained.  Taking questions from social media users, Indian Council of Medical Research’s Dr NK Arora on Friday clarified several issues regarding Covid-19 vaccination.  Union health ministry shared those video messages Read More…

America Corona Virus Life Science medical

Scientists maps “molecular activities on viral infection” resulted in new drugs to Combat Covid-19

Following months of interdisciplinary research assessing tens of thousands of lung cells infected with the novel coronavirus, scientists have created one of the most comprehensive maps to date of the molecular activities that are triggered inside these cells at the onset of the viral infection, an advance that may lead to the development of new Read More…

Companies Corona Virus Indian Subcontinent Life Science Life Style medical

BharatBiotech says Covaxin is to be administered subject to Conditions apply clauses

The move to include Covaxin even before the publication of data from its phase 3 trial had come under criticism from some quarters.   However, the regulator had defended the decision by saying that both the vaccines were totally safe.   Over 500 adverse reactions were reported from across the country during two days of Read More…

Corona Virus Indian Subcontinent Life Science medical

Indians so far 3.8 lakhs vaccinated and 580 found adverse effect : Health Ministry

In india a total of 3,81,305 beneficiaries have so far been vaccinated for coronavirus, even as 580 adverse events following immunization were reported in the country, the Union Health Ministry said on Monday.   Yesterday, for the first time, active cases declined below 2 per cent of the total cases reported in the country.   Read More…

Corona Virus Indian Subcontinent Life Science

Covid-19 Phase 1 vaccination will kick-off on January 16 across India

The much-awaited Covid-19 vaccination drive will kick-off on January 16. Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively.   “As many as Read More…

Corona Virus Health Indian Subcontinent Industries Life Science medical Regulators

Medical Experts questions swift approval of 2 vaccines and ask for data

Healthcare experts on Monday 4 January questioned the government’s assertion that Bharat Biotech’s COVID-19 vaccine Covaxin can target mutated coronavirus strains and maybe used us a ”backup”, as they asked for the scientific basis for the claim and for the vaccine’s safety and efficacy.   India’s country drugs regulator Sunday granted emergency use approval to Read More…